Supported by clinical pipeline innovations, steroid-sparing treatment protocols, and growing investment in pediatric autoimmune care, the systemic juvenile idiopathic arthritis market is poised for sustained global growth through 2033. https://www.datamintelligence.com/research-report/systemic-juvenile-idiopathic-arthritis-market